Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01760291 · ClinicalTrials.gov registry record · NA
Continued Access to PREVAIL (CAP2) - WATCHMAN Left Atrial Appendage (LAA) Closure Technology
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 576
- Enrollment target
NCT01760291: Completed NA study, sponsored by Boston Scientific Corporation.
NCT01760291 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 576 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01760291, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 576 participants
- Enrollment target
Study Summary
To provide additional information about the safety and efficacy of the WATCHMAN LAA Closure Technology
Primary Outcome
Primary Endpoint Events by Type for Enrolled Subjects
Interventions
- DEVICE WATCHMAN LAA Closure Technology
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 576 participants |
| Start Date | 2012-09 |
| Est. Completion | 2019-04 |
| Phase | NA |
What the finished NCT01760291 record still lists
NCT01760291 is an interventional study that assigns participants to a tested intervention. The registered 576 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% lower).
The record links to 0 conditions, and to 1 intervention - of which WATCHMAN LAA Closure Technology is the first listed.
NCT01760291 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01760291 about?
NCT01760291 is a clinical study titled "Continued Access to PREVAIL (CAP2) - WATCHMAN Left Atrial Appendage (LAA) Closure Technology". To provide additional information about the safety and efficacy of the WATCHMAN LAA Closure Technology
What is the current status of trial NCT01760291?
This trial is currently completed. It is a NA study. The enrollment target is 576 participants. The study started on 2012-09. Estimated completion is 2019-04.
What interventions are being tested in trial NCT01760291?
The interventions under investigation include: WATCHMAN LAA Closure Technology (DEVICE).
Who is sponsoring clinical trial NCT01760291?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01760291's enrollment target sits among peer trials
576 177th of 2000 higher than 1,823 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04931810 · 576 participants · NA
Urban and Reservation Implementation of All Nations Breath of Life
- NCT05179369 · 576 participants · NA
Well-Mama Community Doula Navigator Study
- NCT06398509 · 576 participants · NA
A Primary Care Based Intervention to Prevent Childhood Obesity Among Low-income Latino Children
- NCT02610439 · 575 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia